ACR Appropriateness Criteria® Resectable Stomach Cancer.
For resectable gastric cancer, perioperative chemotherapy or adjuvant chemoradiation with chemotherapy are standards of care. The decision making for adjuvant therapeutic management can depend on the stage of the cancer, lymph node positivity, and extent of surgical resection. After gastric cancer resection, postoperative chemotherapy combined with chemoradiation should be incorporated in cases of D0 lymph node dissection, positive regional lymph nodes, poor clinical response to induction chemotherapy, or positive margins. In the setting of a D2 lymph node dissection, especially those with negative regional lymph nodes, adjuvant chemotherapy alone could be considered. The American College of Radiology (ACR) Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review includes an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
Parima
P
Daroui
Salma K
SK
Jabbour
Joseph M
JM
Herman
May
M
Abdel-Wahab
Nilofer
N
Azad
A William
AW
Blackstock
Prajnan
P
Das
Karyn A
KA
Goodman
Theodore S
TS
Hong
William E
WE
Jones
Harmeet
H
Kaur
Andre A
AA
Konski
Albert C
AC
Koong
Rachit
R
Kumar
Timothy M
TM
Pawlik
William
W
Small
Charles R
CR
Thomas
W Warren
WW
Suh
D059248:Chemoradiotherapy; D003131:Combined Modality Therapy; D019317:Evidence-Based Medicine; D006801:Humans; D011379:Prognosis; D013274:Stomach Neoplasms / Q000628:therapy*